Wockhardt’s shares surged 8.6% after its antibiotic Zaynich successfully treated a US cancer patient, enabling a liver transplant and chemotherapy. The drug is nearing Phase III trials for global approval.
Raymond Q2 Results: Net profit jumps 130% YoY to Rs 32 crore, revenue rises 24%
Raymond reported a 130% year-on-year jump in consolidated net profit to Rs 32 crore in Q2 FY27, while revenue rose 24.1% to Rs 655 crore.